Indrajit N. Fernando
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Detailed Sub-study Analysis of the SECRAB Trial: Quality of Life, Cosmesis and Chemotherapy Dose Intensity.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: November 15, 2022
Response to Gultekin et al. regarding SECRAB trial toxicity.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: January 16, 2020
Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 15, 2019
Socioeconomic differences impact overall survival in advanced ovarian cancer (AOC) prior to achievement of standard therapy.
Journal: Archives of gynecology and obstetrics
Published: May 14, 2019
Outcomes Following Interval Debulking Surgery in Primary Peritoneal Carcinoma.
Journal: Anticancer research
Published: January 02, 2016
Survival and Toxicity Following Chemoradiation for Carcinoma of the Cervix - Impact of Multiple-phase Treatment and Shielding.
Journal: Anticancer research
Published: September 27, 2015
Chemotherapy for Uterine Carcinosarcoma with Carboplatin, Ifosfamide and Mesna.
Journal: Anticancer research
Published: August 09, 2015
Chemotherapy for advanced endometrial cancer with carboplatin and epirubicin.
Journal: Anticancer research
Published: July 02, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026